Srdjan R. Stankovic
2020
Compensation breakdown
| Non-Equity Incentive Plan | $379,813 |
|---|---|
| Option Awards | $1,870,608 |
| Salary | $715,869 |
| Stock Awards | $1,864,547 |
| Other | $25,577 |
| Total | $4,856,415 |
Stankovic received $1.9M in option awards, accounting for 39% of the total pay in 2020.
Stankovic also received $379.8K in non-equity incentive plan, $715.9K in salary, $1.9M in stock awards and $25.6K in other compensation.
Rankings
In 2020, Srdjan R. Stankovic's compensation ranked 2,291st out of 13,090 executives tracked by ExecPay. In other words, Stankovic earned more than 82.5% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 2,291 out of 13,090 | 83rd |
Division Manufacturing | 881 out of 5,621 | 84th |
Major group Chemicals And Allied Products | 315 out of 2,254 | 86th |
Industry group Drugs | 267 out of 1,954 | 86th |
Industry Pharmaceutical Preparations | 191 out of 1,459 | 87th |
Pay ratio
| Srdjan R. Stankovic's Pay | $4,856,415 |
|---|---|
| Median Employee's Pay | $218,247 |
| Pay Ratio | 22to 1 |
In 2020, the annual total compensation of Srdjan R. Stankovic was $4,856,415.
The annual total compensation of the median employee at ACADIA Pharmaceuticals was $218,247.
The ratio of Srdjan R. Stankovic's pay to the pay of median employee was therefore 22 to one.
Stankovic's colleagues
We found four more compensation records of executives who worked with Srdjan R. Stankovic at ACADIA Pharmaceuticals in 2020.